Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $1132.5000 (0.67%) ($1132.5000 - $1690.0000) on Mon. Oct. 13, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.63% (three month average) | RSI | 2 | Latest Price | $1132.5000(0.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -10.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -21.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWI(2%) EWP(2%) IWM(2%) SHY(2%) | Factors Impacting CAPR price | CAPR will decline at least -2.315% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.315% (StdDev 4.63%) | Hourly BBV | 0 () | Intraday Trend | -33% | | | |
|
Resistance Level | $1939.56 | 5 Day Moving Average | $1296.5(-12.65%) | 10 Day Moving Average | $1596.24(-29.05%) | 20 Day Moving Average | $1939.56(-41.61%) | To recent high | -55.6% | To recent low | 0.7% | Market Cap | $22.308b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |